Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …

Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

The promise of digital health care continues to be enthusiastically promoted but has been
difficult to realise. Evidence-based practice, along with patient safety assurances, information …

Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…

Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

Background Structured Medication Reviews (SMRs) are intended to help deliver the NHS
Long Term Plan for medicines optimisation in people living with multiple long-term conditions …

Personal Health Records (PHRs) have the potential to give patients fine-grained, personalized
and secure access to their own medical data and to enable self-management of care. …

Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients. …